glp-1 news today november 5 2025 Nutritional priorities to support therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society GLP-1 Agonists Market Report 2025-2033,

Compounded drugs can meet an individual patients needs when FDA-approved drugs arent suitable or available

conducted the present pilot study [2] to examine the ratio of acylcarnitines to free carnitines (AC/FC), a biomarker of cardiomyocyte carnitine insufficiency and impaired -oxidation [3], either in symptomatic HF with reduced left ventricular ejection fraction (LVEF) HFrEF or HF with preserved LVEF (HFpEF), and demonstrated that AC/FC levels in admission were significantly higher than in asymptomatic staged HF, decreasing to comparable levels at discharge

Improves Skin Texture & Tone

Similarly, single doses of 60 mg, 120 mg, and 180 mg taken one hour before oral glucose tolerance testing effectively improved fasting blood glucose levels as well as glucose and insulin responses in pre-diabetic individuals, with 180 mg having the greatest impact on blood glucose levels (Alvarado, Leschot 2016)

Assimos DG